ELIM Rheumatic Centre,
Combination checkpoint inhibitors work better against cancer, but the autoimmune side-effects are worse.
Combination checkpoint inhibitors work better against cancer, but the autoimmune side-effects are worse.
Severe side effects of cancerimmunotherapy, immune checkpoint inhibitors (anti-PD-1 and anti-CTLA-4), were reported from…
チェックポイント阻害薬併用による心筋障害リスクは単独の5倍弱。しかし、頻度は0.27%:Vanderbilt University。 https://t.co/UjPeIURWa4
Immune checkpoint inhibitors (eg novolumab) for CA assoc w/ inflamm arthritis. NEJM report of rhabdo